Sickle Cell Disease Association of America (EIN 222436381) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1982

Legal Domicile

Principal Officer

Stanley Simpkins

Phone

2154718686

Tax Period

2023-07-01 to 2024-06-30

Sickle Cell Disease Association of America, founded in 1982, is a small nonprofit in the Diseases & Disorders sector that reported $431K in total revenue in fiscal year 2023. Revenue surged 44% from the prior year, signaling strong growth momentum. Expenses of $370K left a modest 14% surplus.

Mission

To provide education, screenings, and counseling for persons suffering from sickle cell disease and to stimulate interest and further research for curing the disease.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $431,379

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $431,379

Expense Breakdown

Grants Paid $0

Salaries & Benefits $240,359

Fundraising Expenses $6,265

Program Expenses $295,137

Other Expenses $129,354

TOTAL EXPENSES $369,713

Year-over-Year Comparison

	2023	2022	Change
Revenue	$431,379	$300,395	+0.4%
Expenses	$369,713	$305,437	+0.2%
Net Income	$61,666	$-5,042	-13.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

$80,000

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Wilhemenia Young	Board Member	1.00	Director	$0	$0	$0
Anthony Phillips	Chairman	1.00	Director	$0	$0	$0
Stanley Simpkins	Executive Director	40.00	Key Emp Highest	$80,000	$0	$80,000
Tammy Britt	Board Secretary	1.00	Director	$0	$0	$0
Janee Burkhalter PhD	Board Member	1.00	Director	$0	$0	$0
Aramide Ayorinde	Board Member	1.00	Director	$0	$0	$0
David Q Jones Esq	Vice Chairman	1.00	Officer Director	$0	$0	$0
Georgette Miller Esq	Board Member	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$431,379	$369,713	$84,251	$61,666
2023	$300,395	$305,437	$54,389	$-5,042
2022	$435,670	$260,929	$60,851	$174,741
2020	$297,444	$350,425	$46,316	$-52,981
2019	$339,290	$375,508	$51,576	$-36,218
2018	$276,445	$355,924	$40,847	$-79,479

Sickle Cell Disease Association of America